Clinical Trial Update: Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating gemcitabine and cisplatin given before or after surgery in patients with stage I or stage II non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN